Patient Support Programs (PSP) Market Size, Share & Trends Analysis Report By Functionality (Communication, Health Tracking & Insights, Billing & Payments, Administrative, Patient Education, Others), By Therapeutic area (Health & Wellness, Chronic Disease Management, Others), By Application, By End-user, By Region, And By Segment Forecasts, 2025-2034

Report Id: 2197 Pages: 179 Published: 10 March 2025 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Global Patient Support Programs (PSP) Market Size is valued at USD 21.8 Billion in 2024 and is predicted to reach USD 104.7 Billion by the year 2034  at a 17.1% CAGR during the forecast period for 2025-2034.

Patient Support Programs (PSP) Market

The patient support programs (PSP) market is a rapidly expanding segment of the healthcare and pharmaceutical industries, driven by an increased emphasis on patient-centric care and the desire to improve treatment outcomes. PSPs are in high demand as healthcare becomes more patient-centred. Patients want more than just medication; they want information, support, and resources to manage their health issues effectively. PSPs are particularly common in treating chronic diseases such as diabetes, cancer, and autoimmune disorders.

These programs assist patients in adhering to treatment plans, dealing with side effects, and improving their overall quality of life. The rising frequency of chronic diseases, increased patient demand for comprehensive care, and the use of technology for remote monitoring and participation. Pharmaceutical companies see PSPs as improving patient outcomes while building brand loyalty. PSP providers face regulatory compliance and patient data privacy problems. It can be difficult to secure patient information while navigating complex healthcare legislation.

The PSP market has significant room for expansion, particularly in emerging economies. Digital health technology advancements and growing engagement with healthcare providers present the potential for further innovation and expansion. PSPs can improve patient adherence, overall health outcomes, and healthcare experience, making them an important part of modern healthcare delivery.

Competitive Landscape

Some Major Key Players In The Patient Support Programs (PSP) Market:

  • Allscripts Healthcare, LLC
  • Orion Health
  • Cerner Corporation
  • McKesson Corporation
  • athenahealth, Inc.
  • IBM
  • Medecision
  • GetWellNetwork, Inc.
  • MEDHOST
  • Lincor
  • IQVIA
  • Wolters Kluwer N.V.
  • Force Therapeutics LLC
  • Quil
  • Greenway Health, LLC
  • Mytonomy
  • Klara Technologies, Inc.
  • Solutionreach, Inc.
  • CureMD Healthcare
  • Patient point LLC
  • Vivify Health
  • Nuance Communications, Inc.
  • Others

Market Segmentation:

The Patient Support Programs (PSP) market is segmented based on Functionality, Therapeutic area, Application, and End User. As per the Functionality, the market is segmented as communication, health tracking & insights, billing & payments, administrative support, and patient education. By Therapeutic area, the market is segmented into Health & Wellness and Chronic Disease Management, and other therapeutic area. The market is segmented by application into Population Health Management, Outpatient Health Management, In-patient Health Management, and others. By end user, the market is segmented into payers, providers, and others.

Based On Functionality, The Health Tracking & Insights Segment Is A Major Contributor In The Patient Support Programs (PSP) Market. 

The health tracking & insights category will hold a major share of the global Patient Support Programs (PSP) market 2024. Frequently integrated into digital health solutions, these technologies provide real-time monitoring and data collecting, allowing for individualized care and patient interaction. Data-driven health insights enable healthcare professionals and pharmaceutical businesses to personalize support packages to particular patient needs. This not only improves medication adherence and overall health outcomes, but it also increases the efficacy of PSPs. As a result, including Health Tracking and insights into PSPs is becoming increasingly important, contributing to market growth by offering more targeted and efficient patient support.

The Population Health Management Segment Witnessed Growth At A Rapid Rate.

The population health management segment is estimated to grow rapidly in the global Patient Support Programs (PSP) market PHM techniques are designed to improve the health of entire patient groups, making them an excellent complement to PSPs. PHM enables healthcare providers and payers to identify at-risk individuals and design PSPs to their specific requirements by leveraging data analytics, care coordination, and patient engagement strategies. This proactive strategy improves patient outcomes while simultaneously lowering healthcare expenses. As more healthcare systems embrace PHM, the synergy between PHM and PSPs propels market expansion by providing more efficient, cost-effective, patient-centered care.

The North America Patient Support Programs (PSP) Market Owns A Major Revenue Share In The Region.

The North America Patient Support Programs (PSP) market is leading region. The region is known for its high prevalence of chronic diseases, aging population, and advanced healthcare infrastructure. Furthermore, North American pharmaceutical companies and healthcare providers are rapidly realizing the importance of PSPs in enhancing patient outcomes and satisfaction. Regulatory frameworks and reimbursement mechanisms also aid the adoption of such solutions. North America continues to drive the expansion of the PSP industry, ultimately resulting in better healthcare delivery and patient experiences, with a strong emphasis on patient-centric care, combined with the region's technology prowess and financial investment capability.

In addition, Asia Pacific is projected to grow rapidly in the global Patient Support Programs (PSP) market. Because of the expanding frequency of chronic diseases, increased healthcare investment, and the adoption of patient-centered care, there are prospects for PSP expansion in the region.

Recent Developments:

  • In Sept 2023, Orion Health and Pieces Technologies, Inc. jointly declared an innovative strategic alliance.  By combining the capabilities of Orion Health's Orchestral Health Intelligence Platform (HIP) and Pieces' cutting-edge AI technology, also known as "Pieces," the partnership enabled clinicians and caregivers to utilize a dependable AI solution tuned to locally sourced, comprehensive data.

Patient Support Programs (PSP) Market Report Scope

Report Attribute Specifications
Market Size Value In 2024 USD  21.8  Billion 
Revenue Forecast In 2034 USD 104.7 Billion 
Growth Rate CAGR CAGR of 17.1% from 2025 to 2034
Quantitative Units Representation of revenue in US$ Bn and CAGR from 2025 to 2034
Historic Year 2021 to 2024
Forecast Year 2025-2034
Report Coverage The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends
Segments Covered By Functionality, Therapeutic Area, Application and End-User
Regional Scope North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Country Scope U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia
Competitive Landscape Allscripts Healthcare, LLC; Orion Health; Cerner Corporation; McKesson Corporation; athenahealth, Inc.; IBM; Medecision; GetWellNetwork, Inc.; MEDHOST; Lincor; IQVIA; Wolters Kluwer N.V.; Force Therapeutics LLC; Quil; Greenway Health, LLC; Mytonomy; Klara Technologies, Inc.; Solutionreach, Inc.; CureMD Healthcare; Patient point LLC; Vivify Health; Nuance Communications, Inc. and others
Customization Scope Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape.
Pricing And Available Payment Methods Explore pricing alternatives that are customized to your particular study requirements.

Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Patient Support Programs (PSP) Market Snapshot

Chapter 4. Global Patient Support Programs (PSP) Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: By Functionality Estimates & Trend Analysis

5.1. By Functionality, & Market Share, 2024 & 2034

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021  to 2034 for the following By Functionality:

5.2.1. Communication

5.2.2. Health Tracking & Insights

5.2.3. Billing & Payments

5.2.4. Administrative

5.2.5. Patient Education

5.2.6. Others

Chapter 6. Market Segmentation 2: By Therapeutic area Estimates & Trend Analysis

6.1. By Therapeutic area & Market Share, 2024 & 2034

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021  to 2034 for the following By Therapeutic area:

6.2.1. Health & Wellness

6.2.2. Chronic Disease Management

6.2.3. Others

Chapter 7. Market Segmentation 3: By Application Estimates & Trend Analysis

7.1. By Application & Market Share, 2024 & 2034

7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Application:

7.2.1. Population Health Management

7.2.2. Outpatient Health Management

7.2.3. In-patient Health Management

7.2.4. Others

Chapter 8. Market Segmentation 4: By End-user Estimates & Trend Analysis

8.1. By End-user & Market Share, 2024 & 2034

8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End-user:

8.2.1. Payers

8.2.2. Providers

8.2.3. Others

Chapter 9. Patient Support Programs (PSP) Market Segmentation 5: Regional Estimates & Trend Analysis

9.1. North America

9.1.1. North America Patient Support Programs (PSP) Market revenue (US$ Million) estimates and forecasts By Functionality, 2021-2034

9.1.2. North America Patient Support Programs (PSP) Market revenue (US$ Million) estimates and forecasts By Therapeutic area, 2021-2034

9.1.3. North America Patient Support Programs (PSP) Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034

9.1.4. North America Patient Support Programs (PSP) Market revenue (US$ Million) estimates and forecasts By End-user, 2021-2034

9.1.5. North America Patient Support Programs (PSP) Market revenue (US$ Million) estimates and forecasts by country, 2021-2034

9.2. Europe

9.2.1. Europe Patient Support Programs (PSP) Market revenue (US$ Million) By Functionality, 2021-2034

9.2.2. Europe Patient Support Programs (PSP) Market revenue (US$ Million) By Therapeutic area, 2021-2034

9.2.3. Europe Patient Support Programs (PSP) Market revenue (US$ Million) By Application, 2021-2034

9.2.4. Europe Patient Support Programs (PSP) Market revenue (US$ Million) By End-user, 2021-2034

9.2.5. Europe Patient Support Programs (PSP) Market revenue (US$ Million) by country, 2021-2034

9.3. Asia Pacific

9.3.1. Asia Pacific Patient Support Programs (PSP) Market revenue (US$ Million) By Functionality, 2021-2034

9.3.2. Asia Pacific Patient Support Programs (PSP) Market revenue (US$ Million) By Therapeutic area, 2021-2034

9.3.3. Asia Pacific Patient Support Programs (PSP) Market revenue (US$ Million) By Application, 2021-2034

9.3.4. Asia Pacific Patient Support Programs (PSP) Market revenue (US$ Million) By End-user, 2021-2034

9.3.5. Asia Pacific Patient Support Programs (PSP) Market revenue (US$ Million) by country, 2021-2034

9.4. Latin America

9.4.1. Latin America Patient Support Programs (PSP) Market revenue (US$ Million) By Functionality, (US$ Million) 2021-2034

9.4.2. Latin America Patient Support Programs (PSP) Market revenue (US$ Million) By Therapeutic area, (US$ Million) 2021-2034

9.4.3. Latin America Patient Support Programs (PSP) Market revenue (US$ Million) By Application, (US$ Million) 2021-2034

9.4.4. Latin America Patient Support Programs (PSP) Market revenue (US$ Million) By End-user, (US$ Million) 2021-2034

9.4.5. Latin America Patient Support Programs (PSP) Market revenue (US$ Million) by country, 2021-2034

9.5. Middle East & Africa

9.5.1. Middle East & Africa Patient Support Programs (PSP) Market revenue (US$ Million) By Functionality (US$ Million) 2021-2034

9.5.2. Middle East & Africa Patient Support Programs (PSP) Market revenue (US$ Million) By Therapeutic area, (US$ Million) 2021-2034

9.5.3. Middle East & Africa Patient Support Programs (PSP) Market revenue (US$ Million) By Application (US$ Million) 2021-2034

9.5.4. Middle East & Africa Patient Support Programs (PSP) Market revenue (US$ Million) By End-user, (US$ Million) 2021-2034

9.5.5. Middle East & Africa Patient Support Programs (PSP) Market revenue (US$ Million) by country, 2021-2034

Chapter 10. Competitive Landscape

10.1. Major Mergers and Acquisitions/Strategic Alliances

10.2. Company Profiles

10.2.1. Allscripts Healthcare, LLC

10.2.2. Orion Health

10.2.3. Cerner Corporation

10.2.4. McKesson Corporation

10.2.5. athenahealth, Inc.

10.2.6. IBM

10.2.7. Medecision

10.2.8. GetWellNetwork, Inc.

10.2.9. MEDHOST

10.2.10. Lincor

10.2.11. IQVIA

10.2.12. Wolters Kluwer N.V.

10.2.13. Force Therapeutics LLC

10.2.14. Quil

10.2.15. Greenway Health, LLC

10.2.16. Mytonomy

10.2.17. Klara Technologies, Inc.

10.2.18. Solutionreach, Inc.

10.2.19. CureMD Healthcare

10.2.20. Patient point LLC

10.2.21. Vivify Health

10.2.22. Nuance Communications, Inc.

Segmentation of Patient Support Programs (PSP) Market-

Patient Support Programs (PSP) Market By Functionality-

  • Communication
  • Health Tracking & Insights
  • Billing & Payments
  • Administrative
  • Patient Education
  • Others 

Patient Support Programs (PSP) Market By Therapeutic area-

  • Health & Wellness
  • Chronic Disease Management
  • Others

Patient Support Programs (PSP) Market By Application-

  • Population Health Management
  • Outpatient Health Management
  • In-patient Health Management
  • Others

Patient Support Programs (PSP) Market By End-user-

  • Payers
  • Providers
  • Others

Patient Support Programs (PSP) Market By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa
Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
2087
Security Code field cannot be blank!

Frequently Asked Questions

Patient Support Programs (PSP) Market Size is valued at USD 21.8 Billion in 2024 and is predicted to reach USD 104.7 Billion by the year 2034

Patient Support Programs (PSP) Market expected to grow at a 17.1% CAGR during the forecast period for 2025-2034.

Solutionreach, Inc.; CureMD Healthcare; Patient point LLC; Vivify Health; Nuance Communications, Inc. and others

Functionality, Therapeutic Area, Application and End-User are the key segments of the Patient Support Programs (PSP) Market.

North American region is leading the Patient Support Programs (PSP) Market.
Get Sample Report Enquiry Before Buying